Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027
"Self–Testing Market is valued at USD 5.96 Billion in 2020 and expected to reach USD 8.11 Billion by 2027 with the CAGR of 4.50% over the forecast period."
Self-Testing Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027. Increasing number of viral infections and virus-related diseases is one of the major factors driving the growth of Global Self-Testing Market.
Scope of Global Self-Testing Market Report:
Self–test kits are used for the rapid diagnostic in different diseases. In this test no need of the medical expert. Self-tests are comfortable and convenient as they can be taken at any time and require a small procedure. The self- test kits are used in different condition like, pregnancy self-test, HIV self-test, self-test kits for infertility, self-test kits for STIs and others. The home testing is increasing from 1970 with the pregnancy kit. In the recent years, there are number various kinds of self-testing kits are available in the market. Now these kits are quick and simple tests for ovulation. People can also monitor blood pressure as well as test for HIV, colon cancer, hepatitis C, deteriorating vision, and urinary tract infections. Some products provide results right away, while others are sample collection devices that need to be mailed to a laboratory for processing. Consumers are inclining towards the self-test kit as it’s convenient and gives fast result.
Global Self-Testing Market report is segmented on the basis of product, usage, application, sample, end-user and region & country level. Based upon product type, the market is segmented into diagnostic kits, diagnostic device and diagnostic strips. Based upon usage, the market is divided into disposable and reusable. Based upon application, the market is divided into cholesterol and triglycerides tests, diabetes and glucose tests, blood pressure test, diabetes and glucose test, pregnancy test, urinary tract infection test, STD /STI test fertility test, ovulation test cancer test, transaminase test, thyroid test menopause test, intolerance or celiac disease test, allergy test and anemia test. Based upon sample, the market is divided into the hospital pharmacies, pharmacies and e-commerce.
The regions covered in this Self-Testing market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Self -Testing sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Self -Testing –
PRIMA Lab SA.
bioLytical Laboratories Inc.
OraSure Technologies, Inc
Nectar Lifesciences Limited
Geratherm Medical AG
Johnson & Johnson
B. Braun Holding GmbH
Home Diagnostics Startup Everlywell is Launching an at-Home Coronavirus Test Sample Kit.
March 19th, 2020; Everlywell announces that an at-home collection kit with telehealth diagnosis for COVID-19 will be available to for USD 139. The initial offering of 30,000 collection kits will significantly impact total coronavirus testing capacity in the United States; free telehealth consults are included for those with positive results. By working with multiple labs to scale infrastructure, the company plans to have testing and diagnosis capacity for a quarter of a million people weekly.
Rising Demand of Self-Testing Kits in Hospitals is one of the Major Factors Driving Market Growth.
Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening and growing preference for the self-diagnosis of viral diseases are some of the major factors driving the market growth. In addition, increase in the detection of new, infectious viruses is also supplementing the market growth of self-testing market. For example, according to U.S government; approximately 37.9 million people across the globe with HIV/AIDS in 2018. Of these, 36.2 million were adults and 1.7 million were children. However, complex regulatory scenario regarding the approval for diagnostic tests for viral infections and lack of awareness regarding newer self-testing may hamper the market growth during the forecast period. In spite of that, research and development by self-testing manufacturing companies may create the number of opportunities for the further growth of the market.
Asia Pacific is an Emerging Region in the Global Self-Testing Test Kits Market.
North America held the largest share of the self-testing market in recent years owing to an increasing number of healthcare sectors adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses. Many people in the United States get sick and die from infectious diseases each year. The U.S. and Canada are the major contributors for the growth of the regional market. North America’s market includes productive government regulatory support for encouraging domestic level private investment, which is likely to be a significant factor for the region’s growing healthcare industry. Asia pacific is emerging region in self-testing market due to the increasing population and awareness about health in this region.
Key Benefits for Global Self -Testing Market Report:-
Global self-testing market report covers in depth historical and forecast analysis.
Global self-testing market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global self-testing market report helps to identify opportunities in market place.
Global self-testing market report covers extensive analysis of emerging trends and competitive landscape.
Self -Testing Market Report Coverage
Market Size in 2019:
US$ 5.70 Billion
Market Historical Analysis:
Forecast Period CAGR %:
Market Size Expected to reach in 2026:
US$ 7.79 Billion
Tables, Charts & Figures:
PRIMA Lab SA., bioLytical Laboratories Inc., SelfDiagnostics OÜ, OraSure Technologies, Inc, Nectar Lifesciences Limited, Piramal Enterprises, Cardinal Health, Accuquik, Geratherm Medical AG, Johnson & Johnson, B. Braun Holding GmbH and others.
Product Type, Usage, Application
North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
Self–Testing Market Segmentation:
Cholesterol and Triglycerides Tests
Diabetes and Glucose Tests
Blood Pressure Test
Diabetes and Glucose Test
Urinary Tract Infection Test
STD /STI Test Fertility Test
Ovulation Test Cancer Test
Thyroid Test Menopause Test
Intolerance or Celiac disease Test
By End- User:
By Regional & Country Analysis:
The Middle East and Africa
Rest of Middle East and Africa
Frequently Asked Questions (FAQ) :
North America held the largest share of the self-testing market in recent years owing to an increasing number of healthcare sectors adopting these diagnostic kits to detect various infectious diseases caused by bacteria and viruses.
Self–Testing Market is valued at USD 5.96 Billion in 2020 and expected to reach USD 8.11 Billion by 2027 with the CAGR of 4.50% over the forecast period. Detail Information
Self -Testing report covers prominent player’s PRIMA Lab SA., bioLytical Laboratories Inc., SelfDiagnostics OÜ, OraSure Technologies, Inc, Nectar Lifesciences Limited, Piramal Enterprises, Cardinal Health, Accuquik, Geratherm Medical AG, Johnson & Johnson, B. Braun Holding GmbH and others.
Rapid diagnostic tests are highly adopted for diagnosis, patient management, epidemiology, and screening and growing preference for the self-diagnosis of viral diseases are some of the major factors driving the market growth.
Interested in this report?
• Self–Testing Market Size – Industry Share Report 2027 and Analysis 2019-2025
Self–Testing Market Size, By Product: ( Diagnostic kits, Diagnostic device, Diagnostic strips), By Usage ( Disposable, Reusable, ) By Sample ( Urine, Blood, Stools Oral Swabs ), By End- User: ( Hospital Pharmacies, Pharmacies, E-commerce) Forecast 2021 to 2027
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.